Severe chorea with positive anti-basal ganglia antibodies after herpesencephalitis [7]

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 78, Issue 1, 2007, Pages 105-107

  Marschitz, I ^a   Rodl S ^a   Gruber Sedlmayr, U ^a   Church, A ^b   Giovannoni, G ^b   Zobel, G ^a   Mache, C J ^a   Raith, J ^a   Plecko, B ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; BASEMENT MEMBRANE ANTIBODY; IMMUNOGLOBULIN; METHYLPREDNISOLONE; OXCARBAZEPINE;

BASAL GANGLION; CASE REPORT; CHOREA; CONVALESCENCE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; HERPES SIMPLEX ENCEPHALITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; PLASMAPHERESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT FAILURE;

EID: 33845982908     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2006.090555     Document Type: Letter

References (5)

1. Prober CG. Herpes simplex virus. In: Long SS, Pickering LK, Prober CG, eds. Principles and practice of pediatric infectious diseases. Philadelphia: Churchill Livingstone, 2003:1032-40.
2. Barthez-Carpentier MA, Rozenberg F, Dusaix E, et al. Relapse of herpes simplex encephalitis. J Child Neurol 1995;10:363-7.
3. Church AJ, Dale RC, Giocannoni G. Anti-basal ganglia antibodies: a possible diagnostic utility in idiopathic movement disorders? Arch Dis Child 2004;89:611-14.
4. Stüve O, Nessler S, Hartung HP, et al. Akute disseminierte enzephalomyelitis. Pathogenese, diagnose, behandlung und prognose. Nervenarzt 2005;76:701-7.
5. Lahat E, Barr J, Barkai G, et al. Long term neurological outcome of herpes encephalitis. Arch Dis Child 1999;80:69-71.